Advertisement

Topics

Gen Suisse Company Profile

04:07 EDT 25th June 2018 | BioPortfolio

Nil

Contact

Phone: 41 31 356 73 84
Fax: 41 31 356 73 01
Email: info@gensuisse.ch


News Articles [65 Associated News Articles listed on BioPortfolio]

Credit Suisse remains bullish on Ocado after recently attending European roadshow

Credit Suisse’s analysts pointed out that Ocado shares have fallen by more than 20% over the past 4 weeks, materially underperforming their food retailing peers

MICROSCOPE BINOCULAIRE ANCIEN ” KERN AARAU “. MADE IN SUISSE.

25,50 EUR (2 Enchères)Date de fin: jeudi avr.-5-2018 19:16:08 CESTEnchérir | Ajouter à vos Affaires à suivre Biotech365 : MICROSCOPE BINOCULAIRE ANCIEN ” KERN AARAU “. MADE IN SUI...

Credit Suisse belässt Gerresheimer auf 'Outperform'

Die Schweizer Bank Credit Suisse hat die Einstufung für Gerresheimer nach Zahlen zum ersten Geschäftsquartal auf "Outperform" mit einem Kursziel von 72 Euro belassen. Das Zahlenwerk des Verpackung.....

Shire (SHP) PT Lowered to GBX 4,000 at Credit Suisse Group

The firm presently has an "outperform" rating on the biopharmaceutical company's stock. Credit Suisse Group's price target would suggest a potential upside of 24.92% from the company's pre...

Credit Suisse senkt Ziel für Gerresheimer - 'Outperform'

Die Schweizer Bank Credit Suisse hat das Kursziel für Gerresheimer nach Zahlen von 75 auf 72 Euro gesenkt, aber die Einstufung auf "Outperform" belassen. Zwar sei das vierte Quartal überraschend g.....

Credit Suisse belässt Astrazeneca auf 'Outperform'

Die Schweizer Bank Credit Suisse hat die Einstufung für Astrazeneca auf "Outperform" mit einem Kursziel von 5800 Pence belassen. Nach einer Reihe an Patentabläufen befinde sich der Pharmaherstelle.....

Credit Suisse senkt Ziel für McDonalds - Bleibt 'Outperform'

Die Schweizer Bank Credit Suisse hat das Kursziel für McDonalds von 191 auf 175 US-Dollar gesenkt, aber die Einstufung auf "Outperform" belassen. Analyst Jason West senkte seine Wachstumsschätzung.....

Credit Suisse belässt Roche auf 'Underperform' - Ziel 215 Franken

Die Schweizer Bank Credit Suisse hat die Einstufung für Roche auf "Underperform" mit einem Kursziel von 215 Franken belassen. Die Markterwartungen für den Pharmakonzern erschienen viel zu hoch, sc.....

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Cellular radiance spf 30 [La Prairie, Inc.]

Cellular Radiance Emulsion SPF 30

Asacol [Cardinal Health]

Asacol (mesalamine)Delayed-Release Tablets

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Gen Suisse

Nil

Credit Suisse

We were one of the first investment banks to create specialized global industry groups, each dedicated to providing unmatched industry knowledge to its clients. Each industry is covered by senior prof...

BeFutur (Suisse) S.A.

Considering the vast impact caused by the emergence of the biotechnologies, and eager to play a driving role in these evolutions, BeFutur Biotechnologies and its subsidiaries have set up an exclusive ...

Renaissance Capital Milestones

Renaissance Capital, founded in 1991 and headquartered in Greenwich, CT, is the leading provider of independent research and investment management services focused on newly public companies. The Firm ...

More Information about "Gen Suisse" on BioPortfolio

We have published hundreds of Gen Suisse news stories on BioPortfolio along with dozens of Gen Suisse Clinical Trials and PubMed Articles about Gen Suisse for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gen Suisse Companies in our database. You can also find out about relevant Gen Suisse Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record